https://ir.neogenomics.com/
NeoGenomics, Inc. (NEO)
NeoGenomics, Inc. specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology-focused testing menus in...
neogenomics inc
https://jobs.jobvite.com/neogenomics
NeoGenomics Laboratories Careers
neogenomicslaboratoriescareers
https://www.biospace.com/neogenomics-reports-revenue-of-121-million-in-the-third-quarter
NeoGenomics Reports Revenue of $121 Million in the Third Quarter - BioSpace
Nov 4, 2021 - NeoGenomics, Inc. today announced its third-quarter results for the period ended September 30, 2021.
in thethird quarterneogenomicsreportsrevenue
https://www.biospace.com/neogenomics-to-offer-mobile-phlebotomy-services-for-liquid-biopsy-tests
NeoGenomics to Offer Mobile Phlebotomy Services for Liquid Biopsy Tests - BioSpace
Nov 9, 2020 - NeoGenomics, Inc. (NASDAQ:NEO) , a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced today...
mobile phlebotomyservices forliquid biopsyneogenomicsoffer
https://www.benzinga.com/m-a/21/10/23212765/guardant-health-will-not-go-with-neogenomics-deal-bloomberg
Guardant Health Will Not Go With NeoGenomics Deal: Bloomberg - Guardant Health (NASDAQ:GH),...
guardant healthgo
https://investingnews.com/tag/neogenomics-inc
NeoGenomics Inc. | INN
neogenomics incinn
https://www.macrotrends.net/stocks/charts/NEO/neogenomics/return-on-tangible-equity
NeoGenomics Return on Tangible Equity 2012-2026 | NEO | MacroTrends
Current and historical return on tangible equity values for NeoGenomics (NEO) over the last 10 years. Return on tangible equity can be defined as the amount of...
return on tangible equityneogenomics20122026macrotrends
https://www.insidermonkey.com/blog/neogenomics-inc-nasdaqneo-q1-2024-earnings-call-transcript-1295519/
NeoGenomics, Inc. (NASDAQ:NEO) Q1 2024 Earnings Call Transcript - Insider Monkey
NeoGenomics, Inc. beats earnings expectations. Reported EPS is $-0.02, expectations were $-0.03.
earnings call transcriptneogenomics incq1 2024nasdaq
https://www.businesswire.com/news/home/20250522491999/en/NeoGenomics-Launches-c-MET-CDx-Assay-to-Guide-Treatment-Decisions-for-Advanced-Non-Small-Cell-Lung-Cancer
NeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung...
NeoGenomics announced the commercial launch of c-MET CDx for NSCLC, its c-MET companion diagnostic immunohistochemistry (IHC) assay.
https://companiesmarketcap.com/neogenomics/ps-ratio/
NeoGenomics (NEO) - P/S ratio
Current and historical P/S ratio charts for NeoGenomics (NEO).
p sneogenomicsratio
https://www.biospace.com/neogenomics-inc-schedules-its-q4-and-full-year-2010-earnings-release-for-february-10-2011
NeoGenomics, Inc. Schedules its Q4 and Full Year 2010 Earnings Release for February 10, 2011 -...
https://www.nasdaq.com/market-activity/stocks/neo/historical-nocp
NeoGenomics, Inc. Common Stock (NEO) Historical NOCP | Nasdaq
Get the latest insights on NeoGenomics, Inc. Common Stock (NEO) historical NOCP to help you in your trading and investing decisions.
neogenomics inccommon stockhistoricalnocpnasdaq
https://investingnews.com/neogenomics-appoints-diagnostics-and-lab-services-industry-veteran-john-p-jack-kenny-to-its-board-of-directors/
NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. "Jack" Kenny to its...
Dec 30, 2025 - NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the appointment of...
https://simplywall.st/stocks/us/healthcare/nasdaq-neo/neogenomics/news/market-cool-on-neogenomics-incs-nasdaqneo-revenues-pushing-s
Market Cool On NeoGenomics, Inc.'s (NASDAQ:NEO) Revenues Pushing Shares 27% Lower - Simply Wall St...
NeoGenomics, Inc. ( NASDAQ:NEO ) shareholders won't be pleased to see that the share price has had a very rough month...
https://investingnews.com/neogenomics-to-participate-in-the-44th-annual-j-p-morgan-healthcare-conference/
NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference | INN
Jan 5, 2026 - NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the Company will...
j p morgan
https://www.fxempire.com/stocks/neo/chart
NeoGenomics, Inc. (NEO) Stock Live Chart | FXEmpire
View live NeoGenomics, Inc. stock chart to track the latest price changes. NEO price chart, real-time data, technical analysis tools, and historical trends for...
neogenomics inclive chartstock
https://www.biospace.com/neogenomics-agrees-to-acquire-trapelo-health
NeoGenomics Agrees to Acquire Trapelo Health - BioSpace
Mar 24, 2021 - NeoGenomics, Inc. (NASDAQ:NEO) , a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced today...
neogenomicsagreesacquirehealth
https://www.businesswire.com/news/home/20260407720447/en/NeoGenomics-to-Report-First-Quarter-2026-Financial-Results-on-April-28-2026
NeoGenomics to Report First Quarter 2026 Financial Results on April 28, 2026
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it will report its ...
first quarter 2026financial resultsneogenomicsreport
https://www.fool.com/earnings/call-transcripts/2019/04/30/neogenomics-inc-neo-q1-2019-earnings-call-transcri.aspx
Neogenomics Inc (NEO) Q1 2019 Earnings Call Transcript | The Motley Fool
Apr 30, 2019 - NEO earnings call for the period ending March 31, 2019.
earnings call transcriptneogenomics incq1 2019the motley
https://menafn.com/1109870587/INVESTOR-ALERT-Pomerantz-Law-Firm-Investigates-Claims-On-Behalf-Of-Investors-Of-Neogenomics-Inc-NEO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Neogenomics, Inc....
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Neogenomics, Inc. - NEO. NEW YORK, July 31, 2025 /PRNewswire/ -- Pomerantz LLP...
https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-neogenomics-inc---neo-302535500.html
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc....
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO). Such...
https://www.home.saxo/markets/stocks/neo-xnas
NeoGenomics Inc. stock | Saxo
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of...
neogenomics incstocksaxo
https://www.macrotrends.net/stocks/charts/NEO/neogenomics/roi
NeoGenomics Return on Investment 2012-2026 | NEO | MacroTrends
Current and historical return on investment (ROI) values for NeoGenomics (NEO) over the last 10 years.
return on investmentneogenomics20122026macrotrends
https://www.fool.com/investing/2022/11/11/why-shares-of-neogenomics-jumped-539-this-week/
Why Shares of NeoGenomics Jumped 53.9% This Week | The Motley Fool
Nov 11, 2022 - The cancer screening company showed its turnaround may be working.
https://investingnews.com/neogenomics-to-report-first-quarter-2026-financial-results-on-april-28-2026/
NeoGenomics to Report First Quarter 2026 Financial Results on April 28, 2026 | INN
Apr 7, 2026 - NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it will report its...
first quarter 2026
https://www.businesswire.com/news/home/20250110704604/en/NeoGenomics-Announces-Chief-Executive-Officer-Succession
NeoGenomics Announces Chief Executive Officer Succession
NeoGenomics' Chris Smith will retire as CEO and board member, effective April 1, 2025. Tony Zook will assume the role of CEO at that time.
chief executive officerneogenomicsannouncessuccession
https://capital.com/en-int/markets/shares/neogenomics-share-price-1
NeoGenomics (NEOus) Stock Price Quote Today & Current Price Chart | Capital.com
stock priceneogenomicsneousquotetoday
https://www.fxempire.com/stocks/neo/news
NeoGenomics, Inc. (NEO) Stock Forecasts & News | FXEmpire
Explore the latest news and expert analysis on NeoGenomics, Inc. (NEO) stock. Stay informed with in-depth forecasts, and insightful commentary on NEO stock at...
neogenomics incstock forecastsnews
https://www.fxempire.com/stocks/neo/history
NeoGenomics, Inc. (NEO) Stock Price History | FXEmpire
Get in-depth historical insights into (NEO) NeoGenomics, Inc.'s stock performance. With data on prices, highs, lows, and change percentages, our page allows...
stock price historyneogenomics inc
https://www.finder.com/uk/share-trading/buy-neogenomics-shares
How to buy NeoGenomics shares in the UK | Finder UK
Nov 4, 2021 - Learn how you can invest in NeoGenomics Inc shares and what it'll cost with popular trading platforms. Plus analysis of financials, recent performance and...
how to buyin the ukneogenomicssharesfinder